Moderna’s stock jumps after announcing its COVID-19 shot is nearing authorization for teens in Europe
Shares of Moderna Inc.
MRNA,
+3.41%
gained 4.7% in trading on Friday after the company said that European regulators recommended authorizing its COVID-19 vaccine for teens as young as 12 years old. The European Medicines Agency’s Committee for Medicinal…
